Angelika Mehnert

Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year

W. Wolfgang Fleischhacker, Jonathan Rabinowitz, Georg Kemmler et al. · The British Journal of Psychiatry · 2005 · 102 citations · Full text

Health-Related Quality of Life in Patients With Schizophrenia During Treatment With Long-Acting, Injectable Risperidone

Henry A. Nasrallah, I. Duchesne, Angelika Mehnert et al. · The Journal of Clinical Psychiatry · 2004 · 88 citations

Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany

Gerd Laux, Bart Heeg, Ben A. van Hout et al. · PharmacoEconomics · 2005 · 65 citations

Conventional Depot Formulations, Psychotropic Medication, Pharmacology +6

Minimal injection site pain and high patient satisfaction during treatment with long-acting risperidone

Jean‐Pierre Lindenmayer, Kathleen S. Jarboe, Cynthia A. Bossie et al. · International Clinical Psychopharmacology · 2005 · 56 citations

Pain Therapy, Psychopathology, Pain Medicine +18

Economic Analysis of Galantamine, a Cholinesterase Inhibitor, in the Treatment of Patients with Mild to Moderate Alzheimer’s Disease in The Netherlands

J. Jaime, Maribel Salas, Alexandra Ward et al. · Dementia and Geriatric Cognitive Disorders · 2002 · 53 citations